SNP-610
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SNP-610, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis [Phase 2]